Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BE vs MRNA✓SelectedUSD · MRNABE vs MRNA performance historyLatest closeAs of-1.68%11/19
Stock and ETF performance explorer

BE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+959.3%
MRNA return
+806.0%
Excess return
+153.2%
Maximum drawdown
-84.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.7%+1.3%-3.0%-1.8%
7D-16.7%-13.8%-2.9%-15.2%
30D-24.5%-17.7%-6.8%-22.7%
3M-18.6%+14.3%-32.9%-20.6%
6M-35.7%+336.0%-371.7%-53.8%
YTD+93.5%+575.9%-482.4%+25.5%
1Y+54.3%+724.4%-670.0%-3.8%
3Y+1,237.4%+160.8%+1,076.6%+913.9%
5Y+461.3%-24.4%+485.7%+400.3%
All+959.3%+806.0%+153.2%+869.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling